Author:
Perrotti Michael,Doyle Todd,Kumar Parvesh,McLeod Daryl,Badger William,Prater Susan,Moran Michael,Rosenberg Stuart,Bonatsos Cora,Kreitner Carrie,Kiehl Ralf,Chang Theodore,Kolodziej Michael
Reference33 articles.
1. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;N Engl J Med,2004
2. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004
3. Management of locally advanced prostate cancer: Past, present, future;Swanson;J Urol,2006
4. Evolving role of surgery, radiation, hormone therapy, and chemotherapy in high-risk locally advanced prostate cancer;Mannuel;Clin Genitourin Cancer,2006
5. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer;D'Amico;JAMA,1998
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献